Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3Phase NA 2Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 11Neoplasm, Residual 2Triple Negative Breast Neoplasms 1Recurrence 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myeloid 1Leukemia 1Carcinoma, Non-Small-Cell Lung 1Carcinogenesis 1Breast Neoplasms 1

Interventions

blinatumomab 3Blood Specimen Collection 2Azacitidine 2venetoclax 1ivosidenib 1gilteritinib 1daratumumab 1avapritinib 1Transplantation 1Radiosurgery 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Lenalidomide 1Interferon alpha-2 1Inotuzumab Ozogamicin 1Idarubicin 1High-Throughput Nucleotide Sequencing 1Daunorubicin 1Cytarabine 1Control Groups 1Consolidation Chemotherapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neoplasm, Residual × Azacitidine × Clear all
NCT07131059 2025-08-20

MRD-positive AML Clinical Study

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
120 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06066905 2023-10-27

A Study of Chidamide With AZA in MRD Positive AML After Transplant

Guangdong Provincial People's Hospital

Phase NA Recruiting
60 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡